Apoptosis of human carcinoma cells in the presence of potential anti-cancer drugs: III. Treatment of Colo-205 and SKBR3 cells with: cis-platin, Tamoxifen, Melphalan, Betulinic acid, L-PDMP, L-PPMP, and GD3 ganglioside

Glycoconjugate Journal

Volumn 20, Issue 9, 2003, Pages 563-577

  Basu, Subhash ^a   Ma, Rui ^a   Boyle, Patrick J ^a   Mikulla, Brian ^a   Bradley, Mathew ^a   Smith, Bradley ^a   Basu, Manju ^a   Banerjee, Sipra ^b  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Anti cancer drugs; Apoptosis; Betulinic acid; Carcinoma cells; cis platin; D PDMP; DNA polymerase ; Gangliosides; GD3; Helicase III; L PPMP; Melphalan; Replisome complex; Tamoxifen

Indexed keywords

2 DECANOYLAMINO 3 MORPHOLINO 1 PHENYL 1 PROPANOL; ANTINEOPLASTIC AGENT; BETULIC ACID; CASPASE 3; CELL NUCLEUS DNA; CISPLATIN; GANGLIOSIDE GD3; GLYCOSPHINGOLIPID; MELPHALAN; PHOSPHATIDYLSERINE; PROPIDIUM IODIDE; REPLISOME; TAMOXIFEN; 4 PROPIONYLOXY 4 PHENYL N METHYLPIPERIDINE; 4-PROPIONYLOXY-4-PHENYL-N-METHYLPIPERIDINE; CASP3 PROTEIN, HUMAN; CASPASE; DNA; DNA DIRECTED DNA POLYMERASE BETA; DRUG DERIVATIVE; FLUORESCENT DYE; GANGLIOSIDE; GANGLIOSIDE, GD3; HELICASE; MORPHOLINE DERIVATIVE; PETHIDINE; SPHINGOLIPID; TRITERPENE; ZINC FINGER PROTEIN;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; BREAST ADENOCARCINOMA; CANCER CELL; CARCINOMA CELL; CELL DAMAGE; CELL DIFFERENTIATION; CELL MEMBRANE; CELL NUCLEUS MEMBRANE; COLON CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DNA METABOLISM; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ARTICLE; BIOLOGICAL MODEL; CELL NUCLEUS; CHEMICAL MODEL; CHEMISTRY; FLUORESCENCE MICROSCOPY; METABOLISM; TIME; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASES; CELL LINE, TUMOR; CELL NUCLEUS; CISPLATIN; DNA; DNA HELICASES; DNA POLYMERASE I; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, AGAR GEL; FLUORESCENT DYES; GANGLIOSIDES; GLYCOSPHINGOLIPIDS; HUMANS; MELPHALAN; MEPERIDINE; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; MODELS, CHEMICAL; MORPHOLINES; PROPIDIUM; SIGNAL TRANSDUCTION; SPHINGOLIPIDS; TAMOXIFEN; TIME FACTORS; TRITERPENES; ZINC FINGERS;

EID: 16644400603     PISSN: 02820080     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:GLYC.0000043293.46845.07     Document Type: Conference Paper

References (93)

1. Wyllie AH, Apoptosis: Cell death in tissue regulation. J Pathol 153, 313-6 (1987).
2. Arends MJ, Wyllie AH, Apoptosis: Mechanisms and roles in pathology. Int Rev Exp Pathol 32, 223-54 (1991).
3. Pisha E, Chai H, Lee IS, Chagwedera TE, Farnsworth NR, Cordell GA, Beecher CW, Fong HH, Kinghorn AD, Brown DM, et al., Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med 1, 1046-51 (1995).
4. Ritke MK, Rusnak JM, Lazo JS, Allan WP, Dive C, Heer S, Yalowich JC, Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells. Mol Pharmacol 46, 605-11 (1994).
5. Schmidt ME, Kuzmanoff KL, Ling-Indeck L, Pezzuto JM, Betulinic acid induces apoptosis in human neuroblastoma cell lines. Eur J Cancer 33, 2007-10 (1997).
6. Couldwell WT, Hinton DR, He S, Chen TC, Sebat I, Weiss MH, Law RE, Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines. FEBS Lett 345, 43-6 (1994).
7. Issandou M, Faucher C, Bayard F, Darbon JM, Opposite effects of tamoxifen on in vitro protein kinase C activity and endogenous protein phosphorylation in intact MCF-7 cells. Cancer Res 50, 5845-50 (1990).
8. Devita VT, Hellman S, Rosenberg SA, Biologic Therapy of Cancer, 2nd edition (1995).
9. Ashkenazi A, Dixit VM, Death receptors, signaling and modulation. Science 281, 1305-8 (1998).
10. Basu S, Ma R, Mikulla B, Bradley M, Moulton C, Basu M, Banerjee S, Inokuchi J, Apoptosis of human carcinoma cells in the presence of inhibitors of glycosphingolipid biosynthesis: I. Treatment of Colo-205 and SKBR3 cells with isomers of PDMP and PPMP. Glycoconj J 20(3), 157-68 (2003).
11. Ma R, Koulov A, Basu M, Banerjee S, Goodson H, Basu S, Apoptosis of Colon and Breast Carcinoma Cells in the Presence of Added Disialosyl Gangliosides: II. Treatment of Colo-205 and SKBR3 Cells with GD3 and GD1b. in Glycoconjugates and Cell Signaling, Issue-3; Glycoconj J 20(5), 319-33 (2004).
12. Ray S, Kelley TJ, Fan L, Basu S, Characterization of DNA Pol-alpha/Primase Complex From Embryonic Chicken Brain. India J Biochem Biophys 31, 226-35 (1994).
13. Boyle PJ, Ma R, Moulton C, Vranish J, Banerjee S, Tuteja N, Basu M, Basu S, Changes in the helicase activity of the replication complex during apoptosis of breast and colon carcinoma cells. FASEB J 18(8), page-C289.
14. Gao X, Fisher SG, Emami B, Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 56, 1038-45 (2003).
15. Wingo PA, Jamison PM, Young JL, Gargiullo P, Population-Based Statistics for Women Diagnosed with Inflammatory Breast Cancer (United States). Cancer Causes Control 15, 321-8 (2004).
16. Salami S, Karami-Tehrani F, Biochemical studies of apoptosis induced by tamoxifen in estrogen receptor positive and negative breast cancer cell lines. Clin Biochem 36, 247-53 (2003).
17. Hawkin RA, Arends MJ, Ritchie AA, Langdon S, Miller WR, Tamoxifen increases apoptosis but does not influence markers of proliferation in an MCF-7 xenograft model of breast cancer. Breast 9, 96-106 (2000).
18. Simeone AM, Ekmekcioglu S, Broemeling LD, Grimm EA, Tari AM, A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxide. Mol Cancer Ther 1, 1009-17 (2002).
19. Majumdar SK, Valdellon JA, Brown KA, In vitro Investigations on the toxicity and cell death induced by tamoxifen on two non-breast cancer cell types. J Biomed Biotechnol 1, 99-107 (2001).
20. Tavassoli M, Soltaninia J, Rudnicka J, Mashanyare D, Johnson N, Gaken J, Tamoxifen inhibits the growth of head and neck cancer cells and sensitizes these cells to cis-platin induced-apoptosis: Role of TGF-beta1. Carcinogenesis 23, 1569-75 (2002).
21. Simard M, Zhang W, Hinton DR, Chen TC, Weiss MH, Su YZ, Gopalakrishna R, Law RE, Couldwell WT, Tamoxifen-induced growth arrest and apoptosis in pituitary tumor cells in vitro via a protein kinase C-independent pathway. Cancer Lett 185, 131-8 (2002).
22. Brandt S, Heller H, Schuster KD, Grote J, Tamoxifen induces suppression of cell viability and apoptosis in the human hepatoblastoma cell line HepG2 via down-regulation of telomerase activity. Liver Int 24, 46-54 (2004).
23. Zartman JK, Foreman NK, Donson AM, Fleitz JM, Measurement of tamoxifen-induced apoptosis in glioblastoma by cytometric bead analysis of active caspase-3. J Neurooncol 67, 3-7 (2004).
24. Tseng SH, Wang CH, Lin SM, Chen CK, Huang HY, Chen Y, Activation of c-Jun N-terminal kinase 1 and caspase 3 in the tamoxifen-induced apoptosis of rat glioma cells. J Cancer Res Clin Oncol 130 (5), 285-93 (2004).
25. Gauduchon J, Gouilleux F, Maillard S, Marsaud V, Renoir MJ, Sola B, The selective estrogen receptor modulator 4-hydroxy tamoxifen induces G1 arrest and apoptosis of multiple myeloma cell lines. Ann N Y Acad Sci 1010, 321-5 (2003).
26. Basu S, Ma R, Basu M, Goodson H, Smith B and Banerjee S, Glycosphingolipid metabolism and signaling in apoptotic cancer cells. In Sphingolipid Metabolizing Enzymes, edited by Haldar DK, Das SK, Research Signpost (in press/2004).
27. Seki K, Yoshikawa H, Shiiki K, Hamada Y, Akamatsu N, Tasaka K, Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma. Cancer Chemother Pharmacol 45, 199-206 (2000).
28. Henkels KM, Turchi JJ, Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines. Cancer Res 59, 3077-83 (1999).
29. Kelley TJ, Moghaddas S, Bose R, Basu S, Inhibition of immunopurified DNA polymerase-alpha from PA-3 prostate tumor cells by platinum (II) antitumor drugs, Cancer Biochem Biophys 13, 135-46 (1993).
30. Bose R, Li D, Kennedy M, Basu S, Facile Formation of cis-platin Nanopeptide Complex of Human DNA Polymerase-alpha Origin. J Chem Soc Commun Royal Soc Chem 1731-32 (1995).
31. Bose RN, Li D, Yang WW, Basu S, NMR structures of a non-apeptide from DNA binding domain of human polymerase-alpha determined by iterative complete-relaxation-matrix approach. J Biomol Struct Dyn 16, 1075-85 (1999).
32. Basu S, Basu M, (Volume Co-editors), Liposomes methods and protocols in Methods in Molecular Biol (Series Editor: Walker JM) Humana Press, New York (2001).
33. Cichewicz RH, Kouzi SA, Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection, Med Res Rev 24, 90-114 (2004).
34. Eiznhamer DA, Xu ZQ, Betulinic acid: a promising anticancer candidate, IDrugs 7, 359-73 (2004).
35. Tan Y, Yu R, Pezzuto JM, Betulinic acid-induced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation, Clin Cancer Res 9, 2866-75 (2003).
36. Kwon HJ, Shim JS, Kim JH, Cho HY, Yum YN, Kim SH, Yu J, Betulinic Acid Inhibits Growth Factor-induced in vitro Angiogenesis via the Modulation of Mitochondrial Function in Endothelial Cells, Jpn J Cancer Res 93, 417-25 (2002).
37. Devita VT, Hellman S, Rosenberg SA, Biologic Therapy of Cancer, 2nd edition (1995).
38. Malisan F, Testi R, GD3 in cellular ageing and apoptosis. Exp Gerontol 37, 1273-82 (2002).
39. Paris R, Morales A, Coll O, Sanchez-Reyes A, Garcia-Ruiz C, Fernandez-Checa JC, Ganglioside GD3 sensitizes human hepatoma cells to cancer therapy. J Biol Chem 277, 49870-6 (2002).
40. Watanabe R, Ohyama C, Aoki H, Takahashi T, Satoh M, Saito S, Hoshi S, Ishii A, Saito M, Arai Y, Ganglioside GM3 overexpression induces apoptosis and reduces malignant potential in murine bladder cancer. Cancer Res 62, 3850-4 (2002).
41. Simon BM, Malisan F, Testi R, Nicotera P, Leist M, Disialoganglioside GD3 is released by microglia and induces oligodendrocyte apoptosis. Cell Death Differ 9, 758-67 (2002).
42. Copani A, Melchiorri D, Caricasole A, Martini F, Sale P, Carnevale R, Gradini R, Sortino MA, Lenti L, De Maria R, Nicoletti F, Beta-amyloid-induced synthesis of the ganglioside GD3 is a requisite for cell cycle reactivation and apoptosis in neurons. J Neurosci 22, 3963-8 (2002).
43. Kristal BS, Brown AM, Apoptogenic ganglioside GD3 directly induces the mitochondrial permeability transition. J Biol Chem 274, 23169-75 (1999).
44. Scorrano L, Petronilli V, Di Lisa F, Bernardi P, Commitment to apoptosis by GD3 ganglioside depends on opening of the mitochondrial permeability transition pore. J Biol Chem 274, 22581-5 (1999).
45. Rippo MR, Malisan F, Ravagnan L, Tomassini B, Condo I, Costantini P, Susin SA, Rufini A, Todaro M, Kroemer G, Testi R, GD3 ganglioside directly targets mitochondria in a bcl-2-controlled fashion. Faseb J 14, 2047-54 (2000).
46. Kristal BS, Brown AM, Ganglioside GD3, the mitochondrial permeability transition, and apoptosis. Ann NY Acad Sci 893, 321-4 (1999).
47. Morales A, Colell A, Mari M, Garcia-Ruiz, Fernandez-Checa JC, Glycosphingolipids and mitochondria: role in apoptosis and disease. Glycoconj J 20(5) (in press/2004).
48. Kaufman B, Basu S, Roseman S, Isolation of glucosylceramides from yeast (Hansenula ciferri). J Biol Chem 246, 4266-71 (1971).
49. Dickson RC, Lester RL, Metabolism and selected functions of sphingolipids in the yeast Saccharomyces cerevisiae. Biochim Biophys Acta 1438, 305-21 (1999).
50. Ohashi Y, Tanaka T, Akashi S, Morimoto S, Kishimoto Y, Nagai Y, Squid nerve sphingo-myelin containing an unusual sphingoid base. J Lipid Res 41, 1118-24 (2000).
51. Carter HE, Hendry RA, Mojima S, Stanacer NF, Biochim Biophys Acta 45, 402 (1960).
52. Lester RL, Dickson RC, Sphingolipids with inositolphosphate-containing head groups. Adv Lipid Res 26, 253-74 (1993).
53. Sperling P, Heinz E, Plant sphingolipids: structural diversity, biosynthesis, first genes and functions. Biochim Biophys Acta 1632, 1-15 (2003).
54. Okazaki T, Bell RM, Hannun YA, Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. J Biol Chem 264, 19076-80 (1989).
55. Okazaki T, Bielawska A, Bell RM, Hannun YA, Role of ceramide as a lipid mediator of 1 alpha,25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J Biol Chem 265, 15823-31 (1990).
56. Pettus BJ, Chalfant CE, Hannun YA, Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta 1585, 114-25 (2002).
57. Tilly JL, Kolesnick RN, Sphingolipids, apoptosis, cancer treatments and the ovary: investigating a crime against female fertility. Biochim Biophys Acta 1585, 135-8 (2002).
58. Cuvillier O, Sphingosine in apoptosis signaling. Biochim Biophys Acta 1585, 153-62 (2002).
59. Radin NS, Killing tumours by ceramide-induced apoptosis: A critique of available drugs. Biochem J 371, 243-56 (2003).
60. Bieberich E, Hu B, Silva J, MacKinnon S, Yu RK, Fillmore H, Broaddus WC, Ottenbrite RM, Synthesis and characterization of novel ceramide analogs for induction of apoptosis in human cancer cells. Cancer Lett 181, 55-64 (2002).
61. Basu M, Kelly P, Girzadas M, Li Z, Basu S, Properties of animal ceramide glycanases, Methods Enzymol 311, 287-97 (2000).
62. glycosphingolipids using clam (cercenaria mercenaria) ceramide glycanase. In Methods in Enzymology, edited by Merrill AH, Jr., Hannun YA (Academic Press, NY, 2000), vol. 321, no. B, pp. 196-205.
63. Basu M, Kelly P, O'Donnell P, Miguel M, Bradley M, Sonnino S, Banerjee S, Basu S, Ceramide glycanase activities in human cancer cells, Biosci Rep 19, 449-60 (1999).
64. Ito M, Yamagata T, Purification and characterization of glycosphingolipid-specific endoglycosidases (endoglycoceramidases) from a mutant strain of Rhodococcus sp. Evidence for three molecular species of endoglycoceramidase with different specificities, J Biol Chem 264, 9510-9 (1989).
65. Li SC, DeGasperi R, Muldrey JE, Li YT, A unique glycosphingolipid- splitting enzyme (ceramide-glycanase from leech) cleaves the linkage between the oligosaccharide and the ceramide, Biochem Biophys Res Commun 141, 346-52 (1986).
66. Spiegel S, Milstien S, Functions of a new family of sphingosine-1- phosphate receptors, Biochim Biophys Acta 1484, 107-16 (2000).
67. Igarashi Y, Functional roles of sphingosine, sphingosine 1-phosphate, and methylsphingosines: In regard to membrane sphingolipid signaling pathways, J Biochem (Tokyo) 122, 1080-7 (1997).
68. Keenan TW, Morre DJ, Basu S, Ganglioside biosynthesis. Concentration of glycosphingolipid glycosyltransferases in Golgi apparatus from rat liver. J Biol Chem 249, 310-5 (1974).
69. Basu S, Kaufman B, Roseman S, Enzymatic synthesis of glucocerebroside by a glucosyltransferase from embryonic chicken brain. J Biol Chem 248, 1388-94 (1973).
70. Basu S, Das K, Basu M, Glycosyltransferases in Glycosphingolipid Biosynthesis. In Oligosaccharides in Chemistry and Biology-A Comprehensive Handbook, edited by Ernst B, Sinay P, Hart G (Wiley-VCH Verlag GmbH, Germany, 2000), pp. 329-47.
71. Colell A, Morales A, Fernandez-Checa JC, Garcia-Ruiz C, Ceramide generated by acidic sphingomyelinase contributes to tumor necrosis factor-alpha-mediated apoptosis in human colon HT-29 cells through glycosphingolipids formation. Possible role of ganglioside GD3. FEBS Lett 526, 135-41 (2002).
72. Kannagi R, Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj J 14, 577-84 (1997).
73. Farmer RW, Richtsmeier WJ, Scher RL, Identification of sialyl Lewis-x in squamous cell carcinoma of the head and neck. Head Neck 20, 726-31 (1998).
74. Ugorski M., Laskowska A, Sialyl lewis a: A tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells. Acta Biochimica 49, 303-11 (2002).
75. Kaufman B, Basu S, Embryonic chicken brain sialyltransferases. Methods in Enzymol 8, 365-8 (1966).
76. Basu S, Basu M, Dastgheib S, Hawes JW, Biosynthesis and Regulation of Glycosphingolipids. Comprehensive Natural Products Chemistry, edited by Barton D, Nakanishi K, Meth-Cohen O, B. M. Pinto (Pergamon Press, New York, 1999), Vol. 3, pp. 107-28.
77. Higashi H, Basu M, Basu S, Biosynthesis in vitro of disialosylneolactotetraosylceramide by a solubilized sialyltransferase from embryonic chicken brain, J Biol Chem 260, 824-8 (1985).
78. x by alpha 1-3 fucosyltransferases from colon carcinoma cells and embryonic brain tissues. Glycobiology 1, 527-35 (1991).
79. Basu M, Basu SS, Li Z, Tang H, Basu S, Biosynthesis and regulation of Le(x) and SA-Le(x) glycolipids in metastatic human colon carcinoma cells. Indian J Biochem Biophys 30, 324-32 (1993).
80. Basu M, Khan FA, Das KK, Zhang BJ, Biosynthesis in vitro of core lacto-series glycosphingolipids by N-acetyl-D-glucosaminyltransferases from human colon carcinoma cells, Colo 205. Carbohydr Res 209, 261-77 (1991).
81. Basu M, Basu S, Stoffyn A, Stoffyn P, Biosynthesis in vitro of sialyl(alpha 2-3)neolactotetraosylceramide by a sialyltransferase from embryonic chicken brain. J Biol Chem 257, 12765-9 (1982).
82. Basu SS, Basu M, Li Z, Basu S, Characterization of two glycolipid: alpha 2-3sialyltransferases, SAT-3 (CMP-NeuAc:nLcOse4Cer alpha 2-3sialyltransferase) and SAT-4 (CMP-NeuAc:GgOse4Cer alpha 2-3sialyltransferase), from human colon carcinoma (Colo 205) cell line, Biochemistry 35, 5166-74 (1996).
83. Basu M, De T, Das KK, Kyle JW, Chon HC, Schaeper RJ, Basu S, Glycosyltransferases Involved in Glycolipid Biosynthesis. In Methods in Enzymol edited by Ginsburg V (Academic Press, New York, 1987), vol. 138, pp. 575-607.
84. Basu S, Basu M, Basu SS, Biological Specificity of Sialyltransferases. In Biology of the Sialic Acids, edited by Abraham Rosenberg, (Plenum Press, New York, 1995) pp. 69-94.
85. Basu M, Basu S, Enzymatic synthesis of a tetraglycosylceramide by a galactosyltransferase from rabbit bone marrow, J Biol Chem 247, 1489-95 (1972).
86. Basu S, Basu M, Das KK, Daussin F, Schaeper RJ, Banerjee P, Khan FA, Suzuki I, Solubilized glycosyltransferases and biosynthesis in vitro of glycolipids, Biochimie 70, 1551-63 (1988).
87. Basu S, Basu M, Liposomes and Glycolipid Glycosyltransferases. In Liposomes Methods and Protocols in Methods in Molecular Biol edited by Basu S, Basu M, Walker JM (Humana Press, New York, 2002) pp. 107-30.
88. Das KK, Basu M, Basu S, A rapid preparative method for isolation of neutral and acidic glycosphingolipids by radial thin-layer chromatography. Anal Biochem 143, 125-34 (1984).
89. Wang L, Ma R, Flavell RA, Choi ME, Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-beta 1 in murine mesangial cells. J Biol Chem 277, 47257-62 (2002).
90. Koulov AV, Stucker KA, Lakshmi C, Robinson JP, Smith BD, Detection of apoptotic cells using a synthetic fluorescent sensor for membrane surfaces that contain phosphatidylserine, Cell Death Differ 10, 1357-9 (2003).
91. Fadok VA, Bratton DL, Frasch SC, Warner ML, Henson PM, The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ 5, 551-62 (1998).
92. Eldadah BA, Yakovlev AG, Faden AI, A new approach for the electrophoretic detection of apoptosis, Nucleic Acids Res 24, 4092-3 (1996).
93. Gouaze V, Liu Y-Y, Yu JY, Prickett CS, Giuliano AF, Cabot MC, Blockers of glycolipid metabolism diminishes expression of the multidrug resistance gene (MDR1) and enhances exhemotherapy sensitivity, FASEB J 18(8), C51.